Metabotropic glutamate 2/3 receptor agonist - Eli LillyAlternative Names: mGlu2/3 Agonist - Eli Lilly
Latest Information Update: 28 Oct 2015
At a glance
- Originator Eli Lilly
- Class Small molecules
- Mechanism of Action Metabotropic glutamate receptor 2 agonists; Metabotropic glutamate receptor 3 agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 23 Jan 2014 Phase-I clinical trials in Pain in USA (unspecified route)